These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15081007)

  • 1. 2,3-diarylpyran-4-ones: a new series of selective cyclooxygenase-2 inhibitors.
    Hyup Joo Y; Kwan Kim J; Kang SH; Noh MS; Ha JY; Kyu Choi J; Lim KM; Chung S
    Bioorg Med Chem Lett; 2004 May; 14(9):2195-8. PubMed ID: 15081007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of tetrahydropyran based COX-1/-2 inhibitors.
    Singh P; Bhardwaj A; Kaur S; Kumar S
    Eur J Med Chem; 2009 Mar; 44(3):1278-87. PubMed ID: 18835505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors.
    Caturla F; Jiménez JM; Godessart N; Amat M; Cárdenas A; Soca L; Beleta J; Ryder H; Crespo MI
    J Med Chem; 2004 Jul; 47(15):3874-86. PubMed ID: 15239665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors.
    Navidpour L; Shadnia H; Shafaroodi H; Amini M; Dehpour AR; Shafiee A
    Bioorg Med Chem; 2007 Mar; 15(5):1976-82. PubMed ID: 17258905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New racemosol derivatives as potent cyclooxygenase (COX) inhibitors.
    Songarsa S; Rajviroongit S; Sae-Tang D; Hannongbua S; Kirtikara K; Kittakoop P
    Chem Biodivers; 2005 Dec; 2(12):1635-47. PubMed ID: 17191960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation.
    Khanapure SP; Augustyniak ME; Earl RA; Garvey DS; Letts LG; Martino AM; Murty MG; Schwalb DJ; Shumway MJ; Trocha AM; Young DV; Zemtseva IS; Janero DR
    J Med Chem; 2005 Jun; 48(11):3930-4. PubMed ID: 15916445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
    Ranatunge RR; Augustyniak M; Bandarage UK; Earl RA; Ellis JL; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schroeder JD; Shumway MJ; Tam SW; Trocha AM; Young DV
    J Med Chem; 2004 Apr; 47(9):2180-93. PubMed ID: 15084117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
    Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
    J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of new anti-inflammatory compounds containing the 1,4-benzodioxine and/or pyrrole system.
    Harrak Y; Rosell G; Daidone G; Plescia S; Schillaci D; Pujol MD
    Bioorg Med Chem; 2007 Jul; 15(14):4876-90. PubMed ID: 17517512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes.
    Angelico P; Guarneri L; Velasco C; Cova R; Leonardi A; Clarke DE; Testa R
    BJU Int; 2006 Apr; 97(4):837-46. PubMed ID: 16536784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
    Rao PN; Uddin MJ; Knaus EE
    J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Amino-5-sulfanyl-1,3,4-thiadiazoles: a new series of selective cyclooxygenase-2 inhibitors.
    Sharma R; Sainy J; Chaturvedi SC
    Acta Pharm; 2008 Sep; 58(3):317-26. PubMed ID: 19103568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
    Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
    Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.